510(k) K022093
K022093 is an FDA 510(k) premarket notification submitted by Chase Medical, Inc. for the device "CHASE CARDIOVASCULAR PATCH KIT". The FDA issued a decision of Substantially Equivalent on Sep 20, 2002. The device falls under product code DXZ (Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene), a Class II device regulated under 21 CFR 870.3470. Chase Medical, Inc. has 28 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Sep 20, 2002
- Date Received
- Jun 27, 2002
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene
- Device Class
- Class II
- Regulation Number
- 870.3470
- Review Panel
- CV
- Submission Type
- 510(k)
Need the full FDA record for Chase Medical, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.